홈STAR • NSE
add
Strides Pharma Science Ltd
전일 종가
₹945.45
일일 변동폭
₹918.20 - ₹949.00
52주 변동폭
₹412.10 - ₹993.85
시가총액
863.83억 INR
평균 거래량
34.41만
주가수익률
-
배당수익률
-
기본 거래소
NSE
시장 뉴스
재무
손익계산서
수익
순이익
(INR) | 2024년 3월info | 전년대비 변동 |
---|---|---|
수익 | 108.40억 | 9.90% |
운영비 | 48.78억 | 21.08% |
순이익 | 1.82억 | 290.47% |
순이익률 | 1.68 | 273.20% |
주당 수익 | — | — |
EBITDA | 23.51억 | 133.44% |
유효 세율 | 64.99% | — |
대차대조표
총자산
총부채
(INR) | 2024년 3월info | 전년대비 변동 |
---|---|---|
현금 및 단기 투자 | 29.69억 | -17.68% |
총자산 | 583.98억 | -12.03% |
총부채 | 376.80억 | -15.62% |
총자기자본 | 207.17억 | — |
발행 주식 | 9179.29만 | — |
주가순자산비율 | 4.08 | — |
총자산이익률 | — | — |
자본이익률 | 9.60% | — |
현금 흐름
순현금흐름
(INR) | 2024년 3월info | 전년대비 변동 |
---|---|---|
순이익 | 1.82억 | 290.47% |
영업 현금 흐름 | — | — |
투자 현금 흐름 | — | — |
자금 조달 현금 흐름 | — | — |
순현금흐름 | — | — |
잉여 현금 흐름 | — | — |
정보
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore in southern India. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. Its softgel manufacturing capability consists of an annual capacity of 50,000 machine hours or about three billion softgel capsules. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. In the United States and Canadian markets, the company partners with generic companies to supply retail and hospital generics in injectable products and softgels. In European markets, it has long-term relationships for the development of projects and supply agreements with the European companies. In Australia and New Zealand, the company is engaged in manufacturing and supply of soft gels and value-added manufacturing. The company has development and supply agreements with South African companies. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India. Wikipedia
설립
1990
웹사이트
직원 수
2,850